Does F-FDG PET/CT add value to conventional imaging in clinical assessment of chronic disseminated candidiasis?
Fiche publication
Date publication
décembre 2022
Journal
Frontiers in medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr RUBIO Marie Thérèse
Tous les auteurs :
Rammaert B, Maunoury C, Rabeony T, Correas JM, Elie C, Alfandari S, Berger P, Rubio MT, Braun T, Bakouboula P, Candon S, Montravers F, Lortholary O
Lien Pubmed
Résumé
Chronic disseminated candidiasis (CDC) classically occurs after profound and prolonged neutropenia. The aim of the CANHPARI study was to assess the clinical value of adding F-fluorodeoxyglucose PET/CT to conventional radiology for initial and subsequent evaluations of CDC.
Mots clés
Candida, acute leukemia, candidiasis, hematological malignancy, hematopoietic stem cell transplantation, immune reconstitution inflammatory syndrome, invasive fungal disease
Référence
Front Med (Lausanne). 2022 12 20;9:1026067